Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (Diluted) (2019 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 833.33 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.08 Bn | 5.56 Bn | 220.03 Mn | 83.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.40 Mn |
| Mar 31, 2026 | 82.41 Mn |
| Dec 31, 2025 | 78.98 Mn |
| Sep 30, 2025 | 80.04 Mn |
| Jun 30, 2025 | 77.94 Mn |
| Mar 31, 2025 | 76.15 Mn |
| Dec 31, 2024 | 71.42 Mn |
| Sep 30, 2024 | 71.73 Mn |
| Jun 30, 2024 | 71.00 Mn |
| Mar 31, 2024 | 70.63 Mn |
| Dec 31, 2023 | 71.92 Mn |
| Sep 30, 2023 | 70.19 Mn |
| Jun 30, 2023 | 71.63 Mn |
| Mar 31, 2023 | 69.75 Mn |
| Dec 31, 2022 | 70.42 Mn |
| Sep 30, 2022 | 70.55 Mn |
| Jun 30, 2022 | 69.29 Mn |
| Mar 31, 2022 | 69.14 Mn |
| Dec 31, 2021 | 68.58 Mn |
| Sep 30, 2021 | 68.66 Mn |